HUMAN XTENSIONS LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.3 ILa | +2.78% |
|
+1.61% | -65.82% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 3.17 1.18K | Sales 2023 | 4.95 1.84K | Capitalization | 34.68M 12.91B |
|---|---|---|---|---|---|
| Net income 2022 | -44M -16.38B | Net income 2023 | -36M -13.41B | EV / Sales 2022 | -12,002,594 x |
| Net cash position 2022 | 56.97M 21.22B | Net cash position 2023 | 23.37M 8.7B | EV / Sales 2023 | 2,284,412 x |
| P/E ratio 2022 |
-0.42
x | P/E ratio 2023 |
-0.95
x | Employees | 50 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 46.23% |
More Fundamentals
* Assessed data
More news
| 1 day | +2.78% | ||
| 1 week | +1.61% | ||
| Current month | -3.49% | ||
| 1 month | -7.90% | ||
| 3 months | -27.73% | ||
| 6 months | -61.28% | ||
| Current year | -65.82% |
1 week
41.00
46.00
1 month
41.0049.10
Current year
41.00130.00
1 year
41.00273.20
3 years
41.002 054.00
5 years
41.003 331.00
10 years
41.003 331.00
| Managers | Title | Age | Since |
|---|---|---|---|
Tami Frenkel
CEO | Chief Executive Officer | 62 | 11-12-31 |
Asaf Stolovy
DFI | Director of Finance/CFO | 48 | 15-12-31 |
Barak Klein
COO | Chief Operating Officer | 49 | 19-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eitan Nahum
BRD | Director/Board Member | 74 | 15-02-28 |
Tami Frenkel
CEO | Chief Executive Officer | 62 | 11-12-31 |
Tamar Kfir
BRD | Director/Board Member | 56 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-12 | 44.3 | +2.78% | 8,987 |
| 24-05-09 | 43.1 | +1.41% | 78,112 |
| 24-05-08 | 42.5 | -1.16% | 1,702 |
| 24-05-07 | 43 | +2.63% | 5,816 |
| 24-05-06 | 41.9 | -3.90% | 65,724 |
Delayed Quote TEL AVIV STOCK EXCHANGE, May 12, 2024 at 08:49 am EDT
More quotes
Human Xtensions Ltd is an Israel-based medical robotics company. Human Xtensions Ltd is focused operates in one field of activity namely development, production, marketing and sale of medical devices used mainly to perform minimally invasive surgeries. It develops digital handheld devices that extend the human hand The device acts as a human extension inside the anatomy and restores ease and comfort outside by providing surgeons with proper ergonomic positioning near each patient. Its product portfolio consists HandX an electromechanical, controlled laparoscopic device; Fenestrated Gasper; Monopolar Hook, Needle Holder. The Company operates and serves its customers globally. The company's subsidiary is Human Xtensions Inc.
Calendar
2024-05-26
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -65.82% | 3.18M | |
| +73.46% | 12.41B | |
| -15.61% | 8.23B | |
| +3.88% | 6.46B | |
| +14.69% | 5.5B | |
| -5.88% | 5.33B | |
| +42.58% | 5.1B | |
| -18.32% | 4.05B | |
| -32.61% | 2.54B | |
| +10.80% | 1.99B |
- Stock Market
- Equities
- HUMX Stock